AbbVievsNational Vision

ABBV and EYE stock compared: price, dividend, valuation and results, from SEC filings.

EYE

National Vision Holdings, Inc.

$18.30

Value $1.5B

-1.48%
EYE's page

AbbVie (ABBV) has a market value of $522B and National Vision (EYE) $1.5B. Over the last year, with dividends, ABBV moved +30.3% and EYE -26.0%. The P/E is 50.7 for ABBV and 22.0 for EYE. Dividend yield: ABBV 2.35%, EYE none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$522B

    EYE$1.5B

    ABBV is 359 times EYE

  • Revenue, 12 months

    ABBV$66.0B

    EYE$2.1B

    ABBV is 32 times EYE

  • Net income, 12 months

    ABBV$10.3B

    EYE$66M

    ABBV is 156 times EYE

  • Operating margin

    ABBV32.2%

    EYE5.1%

    27.1 points apart

  • ROIC

    ABBV25.7%

    EYE6.7%

    19.0 points apart

  • P/E

    ABBV50.7

    EYE22.0

    ABBV is 2.3 times EYE

  • Dividend yield

    ABBV2.4%

    EYE0.0%

    2.4 points apart

  • 5-year return

    ABBV+201.5%

    EYE-64.0%

    265.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABBV+201.5%

EYE-64.0%

10020030020222023202420252026
Returns by period
PeriodABBVWith dividendsEYEWith dividends
1 year since November 12, 2025+30.3%Price +26.5%-26.0%Price -26.0%
3 years since November 13, 2023+135.3%+33.0% a yearPrice +112.8%+5.5%+1.8% a yearPrice +5.5%
5 years since November 12, 2021+201.5%+24.7% a yearPrice +152.2%-64.0%-18.5% a yearPrice -64.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbVieEYENational Vision

Valuation

ABBVEYE
Valuation
Price$295.03$18.30
Market value$522B$1.5B
Enterprise value (EV)$592B$1.6B
P/E50.722.0
P/E, 5-year median57.070.1
P/B–1.6
EV/EBIT27.915.6
Free cash flow yield3.6%4.7%

Results and growth

ABBVEYE
Results and growth
Revenue, 12 months$66.0B$2.1B
Net income, 12 months$10.3B$66M
Free cash flow, 12 months$18.9B$68M
Earnings per share, 12 months$5.81$0.81
Revenue growth, year on year8.6%9.0%
Revenue growth a year, past+5.9%over 5 years+3.0%over 5 years
EPS growth a year, past-2.8%over 5 years-3.4%over 5 years

Margins and returns on capital

ABBVEYE
Margins and returns on capital
Gross margin73.7%58.8%
Operating margin32.2%5.1%
Net margin15.7%3.2%
ROIC25.7%6.7%
ROE–7.5%

Balance sheet

ABBVEYE
Balance sheet
Cash$10.8B$60M
Total debt$80.9B$688M
Net debt / EBITDA3.20.9
Interest cover7.1×–

Dividends and buybacks

ABBVEYE
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$6.92–
Dividend growth a year, past+6.6%over 5 years–
Buyback yield0.2%0.2%
Shareholder yield2.5%0.2%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or EYE

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or National Vision?

By market value, AbbVie ($522B) is about 358.9 times National Vision ($1.5B), at today's prices.

How did ABBV and EYE stock do over the last 5 years?

Since November 12, 2021, ABBV's price moved +152.2% and EYE's -64.0%. With dividends: ABBV +201.5% (+24.7% a year), EYE -64.0% (-18.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABBV or EYE?

The dividend yield at today's price is 2.35% for AbbVie and none for National Vision. Over the last twelve months they paid $6.92 and – per share.

What is the P/E of ABBV and EYE?

At today's price, the P/E is 50.7 for ABBV and 22.0 for EYE. The median of the last five years was 57.0 and 70.1, which shows where each stands against its own past.

Which has the higher profit margins, AbbVie or National Vision?

Over the last twelve months, the net margin was 15.7% for AbbVie and 3.2% for National Vision, and the operating margin 32.2% and 5.1%. Revenue was $66.0B and $2.1B.

Which is the better investment, AbbVie or National Vision?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.